Track the OrbusNeich Medical Group Holdings Ltd. share price and the full insider trade history of the company, a publicly traded company based in Hong Kong. Shares are listed on the HK market, under the authority of HKEX. Market capitalisation: €3.3bn. The latest transaction was disclosed on 18 June 2026 (Purchase). Among the most active insiders: Chen Wing Shing. The full history is openly available.
Analysts rate OrbusNeich Medical Group Holdings Ltd. Strong Buy (bullish), based on 2 analysts. Average price target: HK$5.61.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
OrbusNeich Medical Group Holdings Ltd. 是一家专门从事心血管疾病医疗器械开发和制造的公司。它专注于创新和改善患者的临床结果。